Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in ...

Edwards Lifesciences (NYSE:EW) today announced 10-year results from the COMMENCE aortic trial supporting its proprietary ...

The EA UFC 6 news has come in fast and heavy this week. If you're a fan of the series, you're likely fired up to know the retail release is less than two months away, and the beta access begins even ...

Edwards Lifesciences today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were ...

Organisers of the annual Cairn Community Games have highlighted the importance of involving young people in group sports and ...

EW heads into Q1 earnings with TAVR strength, rising estimates and momentum in mitral and tricuspid therapies shaping expectations.

The Korea Semiconductor Industry Association (KSIA) has expanded its Korea-U.S. AI Semiconductor Innovation Center in Silicon Valley, the association said Wednesday. The expansion strengthens a key ...

Edwards Lifesciences Corp (EW) reports a robust 12.7% sales growth in Q1 2026, raises full-year guidance, and showcases significant advancements in TAVR and TMTT segments.

The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...

Edwards Lifesciences today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR ...

The best new toys on Canadian store shelves as the shopping season approaches include a dancing robot and an electronic guessing game, according to a new report. The Canadian Toy Testing Council's ...